Shea Jacqueline Elizabeth — SEC Form 4 filings
SEC reporting owner CIK 1771498. 11 Form 4 filings on record with FilingPulse; latest filed 2026-05-21.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-28 to 2026-05-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 46.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | Chief Executive Officer, Director | 11 | — | — | 46 |
Form 4 filings — Shea Jacqueline Elizabeth
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-21 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 28,296 · Tax withholding (F): 12,306 @ $1.23 · Option exercise (M): 28,296 (derivative) @ $0 · Grant/award (A): 123,760 (derivative) @ $0 · Grant/award (A): 100,240 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 17,744 · Tax withholding (F): 7,717 @ $1.30 · Option exercise (M): 17,744 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/award (A): 97,240 (derivative) @ $0 · Grant/award (A): 78,760 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 18,632 · Tax withholding (F): 8,057 @ $1.79 · Option exercise (M): 28,401 · Tax withholding (F): 13,657 @ $1.79 · Option exercise (M): 18,632 (derivative) @ $0 · Option exercise (M): 28,401 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/award (A): 84,888 (derivative) @ $0 · Grant/award (A): 105,262 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 17,744 · Tax withholding (F): 7,717 @ $1.95 · Option exercise (M): 17,744 (derivative) @ $0 | EDGAR |
| 2025-05-12 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 5,500 · Tax withholding (F): 2,392 @ $1.80 · Option exercise (M): 5,500 (derivative) @ $0 | EDGAR |
| 2025-02-28 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 5,852 · Tax withholding (F): 2,493 @ $1.98 · Option exercise (M): 18,632 · Tax withholding (F): 9,088 @ $1.98 · Option exercise (M): 5,852 (derivative) @ $0 · Option exercise (M): 18,632 (derivative) @ $0 · +2 more | EDGAR |
| 2024-05-16 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 17,745 · Tax withholding (F): 7,718 @ $13.07 · Option exercise (M): 17,745 (derivative) @ $0 | EDGAR |
| 2024-05-13 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 5,500 · Tax withholding (F): 2,392 @ $10.65 · Option exercise (M): 5,500 (derivative) @ $0 | EDGAR |
| 2024-02-28 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 1,878 · Tax withholding (F): 872 @ $8.16 · Option exercise (M): 5,853 · Tax withholding (F): 2,856 @ $8.16 · Option exercise (M): 1,878 (derivative) @ $0 · Option exercise (M): 5,853 (derivative) @ $0 · +2 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1771498 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →